Characteristics of double heterozygosity for BRCA1 and BRCA2 germline mutations in Korean breast cancer patients

Breast Cancer Research and Treatment

Volumn 131, Issue 1, 2012, Pages 217-222

  Noh, Jae Myoung ^a   Choi, Doo Ho ^a   Nam, Seok Jin ^a   Lee, Jeong Eon ^a   Kim, Jong Won ^a   Kim, Sung Won ^b   Kang, Eunyoung ^b   Lee, Min Hyuk ^c   Ahn, Sei Hyun ^d   Kim, Ku Sang ^e   Park, Sue K ^b,f   Haffty, Bruce G ^g  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b Seoul National University College of Medicine   (South Korea)

^c Soonchunhyang University College of Medicine   (South Korea)

^d University of Ulsan College of Medicine   (South Korea)

^e Ajou University School of Medicine   (South Korea)

^f Seoul National University   (South Korea)

^g ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

BRCA1 gene; BRCA2 gene; Breast cancer; Heterozygote

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; PROGESTERONE RECEPTOR;

ADULT; ARTICLE; BRCA2 GENE; BREAST CANCER; CANCER GRADING; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; ESOPHAGUS CANCER; FRAMESHIFT MUTATION; GENE IDENTIFICATION; GENE MUTATION; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC SCREENING; GERM LINE; HETEROZYGOSITY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INTRADUCTAL CARCINOMA; KOREA; MUTATIONAL ANALYSIS; NONSENSE MUTATION; ONCOGENE; OVARY CANCER; PHENOTYPE; PRIORITY JOURNAL; RISK ASSESSMENT; TUMOR DIFFERENTIATION;

ADULT; BRCA1 PROTEIN; BRCA2 PROTEIN; BREAST NEOPLASMS; DNA MUTATIONAL ANALYSIS; FEMALE; GENETIC TESTING; GERM-LINE MUTATION; HETEROZYGOTE; HUMANS; MIDDLE AGED; MUTATION; NEOPLASM STAGING; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; REPUBLIC OF KOREA;

EID: 84856210660     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-011-1718-5     Document Type: Article

References (30)

1. SH Ahn KY Yoo 2006 Chronological changes of clinical characteristics in 31, 115 new breast cancer patients among Koreans during 1996-2004 Breast Cancer Res Treat 99 209 214 10.1007/s10549-006-9188-x 16862450 10.1007/s10549-006-9188- x
2. SS Ko 2008 Chronological changing patterns of clinical characteristics of Korean breast cancer patients during 10 years (1996-2006) using nationwide breast cancer registration on-line program: biannual update J Surg Oncol 98 318 323 10.1002/jso.21110 18623175 10.1002/jso.21110
3. BH Son BS Kwak JK Kim HJ Kim SJ Hong JS Lee UK Hwang HS Yoon SH Ahn 2006 Changing patterns in the clinical characteristics of Korean patients with breast cancer during the last 15 years Arch Surg 141 155 160 10.1001/archsurg.141.2. 155 16490892 10.1001/archsurg.141.2.155 (Pubitemid 43276565)
4. D Ford DF Easton J Peto 1995 Estimates of the gene frequency of BRCA1 and its contribution to breast and ovarian cancer incidence Am J Hum Genet 57 1457 1462 8533776 1:CAS:528:DyaK28XktFSisw%3D%3D
5. Y Miki J Swensen D Shattuck-Eidens PA Futreal K Harshman S Tavtigian Q Liu C Cochran LM Bennett W Ding, et al. 1994 A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1 Science 266 66 71 7545954 10.1126/science.7545954 1:CAS:528:DyaK2MXhtF2ns70%3D (Pubitemid 24345325)
6. M Robson T Gilewski B Haas D Levin P Borgen P Rajan Y Hirschaut P Pressman PP Rosen ML Lesser L Norton K Offit 1998 BRCA-associated breast cancer in young women J Clin Oncol 16 1642 1649 9586873 1:STN:280:DyaK1c3ks1artw%3D%3D
7. R Wooster G Bignell J Lancaster S Swift S Seal J Mangion N Collins S Gregory C Gumbs G Micklem 1995 Identification of the breast cancer susceptibility gene BRCA2 Nature 378 789 792 10.1038/378789a0 8524414 10.1038/378789a0 1:CAS:528:DyaK28XltFWi (Pubitemid 26004412)
8. JH Oh DY Noh KJ Choe SB Kang LS Kim MS Ro 1995 Germline mutation of BRCA1 gene in Korean breast and ovarian cancer patients J Korean Cancer Ass 27 1061 1069
9. HC Kang IJ Kim JH Park HJ Kwon YJ Won SC Heo SY Lee KH Kim Y Shin DY Noh DH Yang KJ Choe BH Lee SB King JG Park 2002 Germline mutations of BRCA1 and BRCA2 in Korean breast and/or ovarian cancer families Hum Mutat 20 235 10.1002/humu.9059 12204006 10.1002/humu.9059
10. SH Ahn UK Hwang BS Kwak HS Yoon BK Ku HJ Kang JS Kim BK Ko CD Ko KS Yoon DY Cho BH Son 2004 Prevalence of BRCA1 and BRCA2 mutations in Korean breast cancer patients J Korean Med Sci 19 269 274 15082902 10.3346/jkms.2004.19.2.269 1:CAS:528:DC%2BD2cXksVSkt74%3D (Pubitemid 38591803)
11. DH Choi MH Lee AE Bale D Carter BG Haffty 2004 Incidence of BRCA1 and BRCA2 mutations in young Korean breast cancer patients J Clin Oncol 22 1638 1645 10.1200/JCO.2004.04.179 15117986 10.1200/JCO.2004.04.179 1:CAS:528: DC%2BD2cXpsVWmu7c%3D (Pubitemid 41079802)
12. JH Seo DY Cho SH Ahn KS Yoon CS Kang HM Cho HS Lee JJ Choe CW Choi BS Kim SW Shin YH Kim JS Kim GS Son JB Lee BH Koo 2004 BRCA1 and BRCA2 germline mutations in Korean patients with sporadic breast cancer Hum Mutat 24 350 10.1002/humu.9275 15365993 10.1002/humu.9275
13. SH Han KR Lee DG Lee BY Kim KE Lee WS Chung 2006 Mutation analysis of BRCA1 and BRCA2 from 793 Korean patients with sporadic breast cancer Clin Genet 70 496 501 10.1111/j.1399-0004.2006.00717.x 17100994 10.1111/j.1399-0004.2006. 00717.x (Pubitemid 44741471)
14. SH Ahn BH Son KS Yoon DY Noh W Han SW Kim ES Lee HL Park YJ Hong JJ Choi SY Moon MJ Kim KH Kim BS Kwak DY Cho 2007 BRCA1 and BRCA2 germline mutations in Korean breast cancer patients at high risk of carrying mutations Cancer Lett 245 90 95 10.1016/j.canlet.2005.12.031 16455195 10.1016/j.canlet.2005.12.031 1:CAS:528:DC%2BD2sXht1emtQ%3D%3D (Pubitemid 46001501)
15. BG Haffty DH Choi S Goyal A Silber K Ranieri E Matloff MH Lee M Nissenblatt D Toppmeyer MS Moran 2009 Breast cancer in young women (YBC): prevalence of BRCA1/2 mutations and risk of secondary malignancies across diverse racial groups Ann Oncol 20 1653 1659 10.1093/annonc/mdp051 19491284 10.1093/annonc/mdp051 1:STN:280:DC%2BD1MnjvFOhtw%3D%3D
16. DH Choi MH Lee BG Haffty 2006 Double heterozygotes for non-Caucasian families with mutations in BRCA-1 and BRCA-2 genes Breast J 12 216 220 10.1111/j.1075-122X.2006.00245.x 16684319 10.1111/j.1075-122X.2006.00245.x 1:CAS:528:DC%2BD28Xls1Squ70%3D (Pubitemid 43966634)
17. E Friedman R Bar-Sade Bruchim A Kruglikova S Risel E Levy-Lahad D Halle E Bar-On R Gershoni-Baruch E Dagan I Kepten T Peretz I Lerer N Wienberg A Shushan AD Abeliovich 1998 Double heterozygotes for the Ashkenazi founder mutations in BRCA1 and BRCA2 genes Am J Hum Genet 63 1224 1227 9758598 10.1086/302040 1:STN:280:DyaK1cvjtFyjug%3D%3D (Pubitemid 30418594)
18. TS Frank AM Deffenbaugh JE Reid M Hulick BE Ward B Lingenfelter KL Gumpper T Scholl SV Tavtigian DR Pruss GC Critchfield 2002 Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10, 000 individuals J Clin Oncol 20 1480 1490 11896095 10.1200/JCO.20.6.1480 1:CAS:528:DC%2BD38XivFeisbY%3D (Pubitemid 34260526)
19. B Leegte AH van der Hout AM Deffenbaugh MK Bakker IM Mulder A ten Berge EP Leenders J Wesseling J de Hullu N Hoogerbrugge MJ Ligtenberg A Ardern-Jones E Bancroft A Salmon J Barwell R Eeles JC Oosterwijk 2005 Phenotypic expression of double heterozygosity for BRCA1 and BRCA2 germline mutations J Med Genet 42 e20 10.1136/jmg.2004.027243 15744030 10.1136/jmg.2004.027243 1:STN:280: DC%2BD2M7htlGisQ%3D%3D
20. WA Spannuth PH Thaker AK Sood 2007 Concomitant BRCA1 and BRCA2 gene mutations in an Ashkenazi Jewish woman with primary breast and ovarian cancer Am J Obstet Gynecol 196 e6 e9 10.1016/j.ajog.2007.01.026 17403394 10.1016/j.ajog.2007.01.026 (Pubitemid 46497936)
21. O Lavie S Narod F Lejbkowicz S Dishon Y Goldberg O Gemer G Rennert 2010 Double heterozygosity in the BRCA1 and BRCA2 genes in the Jewish population Ann Oncol 22 964 966 10.1093/annonc/mdq460 20924075 10.1093/annonc/mdq460
22. EK Kim KS Kim SK Park SH Ahn MH Lee SW Kim 2007 The Korean Hereditary Breast Cancer (KOHBRA) study: protocol review J Breast Cancer 10 241 247 10.4048/jbc.2007.10.4.241
23. SA Han SK Park S Hyun Ahn M Hyuk Lee DY Noh LS Kim WC Noh Y Jung K Sang Kim SW Kim Korean Breast Cancer Study Group 2011 The Korean Hereditary Breast Cancer (KOHBRA) Study: protocols and interim report Clin Oncol (R Coll Radiol) 23 434 441 10.1016/j.clon.2010.11.007 10.1016/j.clon.2010.11.007
24. M Zuradelli B Peissel S Manoukian D Zaffaroni M Barile V Pensotti U Cavallari G Masci F Mariette AC Benski A Santoro P Radice 2010 Four new cases of double heterozygosity for BRCA1 and BRCA2 gene mutations: clinical, pathological, and family characteristics Breast Cancer Res Treat 124 251 258 10.1007/s10549-010-0853-8 20373018 10.1007/s10549-010-0853-8 1:CAS:528:DC%2BC3cXht1elsLnL
25. KA Phillips 2000 Immunophenotypic and pathologic differences between BRCA1 and BRCA2 hereditary breast cancers J Clin Oncol 18 107S 112S 11060337 1:CAS:528:DC%2BD3cXot1antLo%3D
26. DA Levine PA Argenta CJ Yee DS Marshall N Olvera F Bogomolniy JA Rahaman ME Robson K Offit RR Barakat RA Soslow J Boyd 2003 Fallopian tube and primary peritoneal carcinomas associated with BRCA mutations J Clin Oncol 21 4222 4227 10.1200/JCO.2003.04.131 14615451 10.1200/JCO.2003.04.131 1:CAS:528: DC%2BD2cXpsVajtrc%3D (Pubitemid 46606192)
27. The Breast Cancer Linkage Consortium 1999 Cancer risks in BRCA2 mutation carriers. The Breast Cancer Linkage Consortium J Natl Cancer Inst 91 1310 1316 10.1093/jnci/91.15.1310
28. D Thompson DF Easton 2002 Cancer Incidence in BRCA1 mutation carriers J Natl Cancer Inst 94 1358 1365 12237281 1:CAS:528:DC%2BD38Xnt1Gnurs%3D (Pubitemid 35154140)
29. Augustyn AM, Agostino NM, Namey TL, Nair S, Martino MA (2011) Two patients with germline mutations in both BRCA1 and BRCA2 discovered unintentionally: a case series and discussion of BRCA testing modalities. Breast Cancer Res Treat. doi: 10.1007/s10549-011-1597-9
30. K Metcalfe S Gershman HT Lynch P Ghadirian N Tung C Kim-Sing OI Olopade S Domchek J McLennan A Eisen WD Foulkes B Rosen P Sun SA Narod 2011 Predictors of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers Br J Cancer 104 1384 1392 10.1038/bjc.2011.120 21487411 10.1038/bjc.2011.120 1:CAS:528:DC%2BC3MXlt1GktL8%3D